The hERG inhibition at 1uM of a drug with the SMILES C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)[C@H](CCCC[NH3+])n3cc(CCCC)nn3)CC2)nc(N2CCN(C(=O)[C@H](CCCC[NH3+])n3cc(CCC(=O)O)nn3)CC2)n1.[Cl-] is 10.465\%.
The {herg_central_at_1uM__names__noun} of a {#drug|compound!} with the {SMILES__description} {SMILES#} is {herg_central_at_1uM#}{herg_central_at_1uM__units}.
C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)[C@H](CCCC[NH3+])n3cc(CCCC)nn3)CC2)nc(N2CCN(C(=O)[C@H](CCCC[NH3+])n3cc(CCC(=O)O)nn3)CC2)n1.[Cl-]
C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)[C@H](CCCC[NH3+])n3cc(CCCC)nn3)CC2)nc(N2CCN(C(=O)[C@H](CCCC[NH3+])n3cc(CCC(=O)O)nn3)CC2)n1.[Cl-]
[(5S)-6-[4-[4-[4-[(2S)-6-azaniumyl-2-(4-butyltriazol-1-yl)hexanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-5-[4-(2-carboxyethyl)triazol-1-yl]-6-oxohexyl]azanium;chloride